SHShane M. Harding

Shane M. Harding

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shane M. Harding has a total of 164 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The proteomic landscape of genotoxic stress-induced micronuclei

    by Kate M. MacDonald, Shahbaz Khan, Brian Lin, Rose Hurren, Aaron D. Schimmer, Thomas Kislinger, Shane M. Harding


  • Open Access

    The entanglement of DNA damage and pattern recognition receptor signaling

    by Cindy T. Ha, Maha M. Tageldein, Shane M. Harding


  • Memory T Cells in the Immunoprevention of Cancer: A Switch from Therapeutic to Prophylactic Approaches

    by Siddhesh Mittra, Shane M. Harding, Susan M. Kaech

    Cancer immunoprevention, the engagement of the immune system to prevent cancer, is largely overshadowed by therapeutic approaches to treating cancer after detection. Vaccines or, alternatively, the utilization of genetically engineered memory T cells could be methods of engaging and creating cancer-specific T cells with superb memory, lenient activation requirements, potent antitumor cytotoxicity, tumor surveillance, and resilience against immunosuppressive factors in the tumor microenvironment. In this review we analyze memory T cell subtypes based on their potential utility in cancer immunoprevention with regard to longevity, localization, activation requirements, and efficacy in fighting cancers. A particular focus is on how both tissue-resident memory T cells and stem memory T cells could be promising subtypes for engaging in immunoprevention.


  • Open Access

    The proteomic landscape of genotoxic stress-induced micronuclei

    by Kate M. MacDonald, Shahbaz Khan, Thomas Kislinger, Shane M. Harding

    SUMMARY: Micronuclei (MN) are induced by various genotoxic stressors and amass nuclear- and cytoplasmic-resident proteins, priming the cell for MN-driven signalling cascades. Here, we measure the proteome of micronuclear, cytoplasmic, and nuclear fractions from human cells exposed to a panel of six genotoxins, comprehensively profiling their MN protein landscape. We find that MN assemble a proteome distinct from both surrounding cytoplasm and parental nuclei, with a core composition that is independent of the specific inciting stressor. Across stress conditions, MN are significantly depleted for spliceosome machinery and replication stress response proteins, but are enriched for a subset of the replisome. We find that the loss of splicing machinery within transcriptionally active MN contributes to intra-MN DNA damage, a known precursor to chromothripsis. This dataset represents a unique resource detailing the proteomic landscape of MN, guiding mechanistic studies of MN generation and MN-associated outcomes of genotoxic stress.

  • Open Access

    Antecedent chromatin organization determines cGAS recruitment to ruptured micronuclei

    by Kate M. MacDonald, Shirony Nicholson-Puthenveedu, Maha M. Tageldein, Sarika Khasnis, Cheryl H. Arrowsmith, Shane M. Harding

    Micronuclei (MN) are cytosolic bodies that sequester acentric fragments or mis-segregated chromosomes from the primary nucleus. Spontaneous rupture of the MN envelope allows recognition by the viral receptor cyclic GMP-AMP synthase (cGAS), initiating interferon signaling downstream of DNA damage. Here, we demonstrate that MN rupture is permissive but not sufficient for cGAS localization. Chromatin characteristics such as histone 3, lysine 79 dimethylation (H3K79me2) are present in the nucleus before DNA damage, retained in ruptured MN, and regulate cGAS recruitment. cGAS is further responsive to dynamic intra-MN processes occurring prior to rupture, including transcription. MN chromatin tethering via the nucleosome acidic patch is necessary for cGAS-dependent interferon signaling. Our data suggest that both damage-antecedent nuclear chromatin status and MN-contained chromatin organizational changes dictate cGAS recruitment and the magnitude of the cGAS-driven interferon cascade. Our work defines MN as integrative signaling hubs for the cellular response to genotoxic stress.


  • Open Access

    Abstract 5704: IDH2 mutation reduce radiotherapy induced immune response in glioblastoma by affecting micronucleus formation

    by Sara Mahmoud Elkashef, Shirony Nicholson, Shane Harding

    DNA methylation is the most abundant epigenetic modification, it plays a critical role in tissue homeostasis, genomic stability, and mitotic fidelity. Isocitrate dehydrogenase genes (IDH1/2) are non-redundantly mutated in several types of cancers including Glioblastoma (GBM), and their mutation induces a DNA hypermethylation phenotype. Radiotherapy (RT), either alone or in combination with other treatments, forms a primary intervention for GBM but the full scope of how IDH1/2 mutations influence this response are not known. In this work, we demonstrate that IDH2 mutation reduces the formation of post-RT micronuclei (MN), small DNA bodies in the cytoplasm distinct from the primary nucleus. Previously, MN has been found to recruit the pattern recognition receptor cGAS to activate an interferon-mediated signalling cascade via STING. We demonstrate that hypermethylation induced by IDH2 mutation does not impact cGAS localization to MN but instead reduces the overall burden of MN which correlates with decreased cGAS-STING mediated transcriptional activation. Mechanistically, IDH2 mutation drives centromeric hypermethylation which stabilizes kinetochore assembly and the fidelity of mitotic chromosome segregation post radiation. We also demonstrate that a reduction of MN formation in IDH2 mutant tumors reduces synergy between RT and immune checkpoint blockade in murine glioma models. Together our data suggest that metabolic alterations in cancers directly influence mitotic fidelity and response to RT with important implications for combination treatments that capitalize on synergy with the innate cellular signalling toward the adaptive immune system. Citation Format: Sara Mahmoud Elkashef, Shirony Nicholson, Shane Harding. IDH2 mutation reduce radiotherapy induced immune response in glioblastoma by affecting micronucleus formation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5704.

  • Top Cited Papers
    Open Access

    The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness

    by Geethu Emily Thomas, Grace Egan, Laura García-Prat, Aaron Botham, Veronique Voisin, Parasvi S. Patel, Fieke W. Hoff, Jordan Chin, Boaz Nachmias, Kerstin B. Kaufmann, et al.

    Mitochondrial metabolites regulate leukaemic and normal stem cells by affecting epigenetic marks. How mitochondrial enzymes localize to the nucleus to control stem cell function is less understood. We discovered that the mitochondrial metabolic enzyme hexokinase 2 (HK2) localizes to the nucleus in leukaemic and normal haematopoietic stem cells. Overexpression of nuclear HK2 increases leukaemic stem cell properties and decreases differentiation, whereas selective nuclear HK2 knockdown promotes differentiation and decreases stem cell function. Nuclear HK2 localization is phosphorylation-dependent, requires active import and export, and regulates differentiation independently of its enzymatic activity. HK2 interacts with nuclear proteins regulating chromatin openness, increasing chromatin accessibilities at leukaemic stem cell-positive signature and DNA-repair sites. Nuclear HK2 overexpression decreases double-strand breaks and confers chemoresistance, which may contribute to the mechanism by which leukaemic stem cells resist DNA-damaging agents. Thus, we describe a non-canonical mechanism by which mitochondrial enzymes influence stem cell function independently of their metabolic function.


  • Open Access

    cGAS recruitment to micronuclei is dictated by pre-existing nuclear chromatin status

    by Kate M. MacDonald, Shirony Nicholson-Puthenveedu, Maha M. Tageldein, Cheryl Arrowsmith, Shane M. Harding

    SUMMARY: Micronuclei (MN) are aberrant cytosolic compartments containing broken genomic fragments or whole lagging chromosomes. MN envelopes irreversibly rupture, allowing the viral receptor cGAS to localize to MN and initiate an inflammatory signalling cascade. Here, we demonstrate that MN envelope rupture is not sufficient for cGAS localization. Unlike MN that arise following ionizing radiation (IR), ruptured MN generated from acute transcription stressors DRB or siSRSF1 are refractory to cGAS localization. Recruitment of cGAS to MN is blocked by inhibiting the histone methyltransferase DOT1L prior to IR exposure, demonstrating that cGAS recruitment to MN is dictated by nuclear chromatin organization at the time of DNA damage. Loss of cGAS+ MN, caused either by acute transcription stressors or by preventing DOT1L-deposited histone methylation, corresponded to significantly decreased cGAS-dependent inflammatory signalling. These results implicate nuclear chromatin organization in micronuclear composition and activity, influencing the ability of damage-induced MN to retain cytosolic proteins upon rupture.


  • Open Access

    Cell Cycle Checkpoints Cooperate to Suppress DNA- and RNA-Associated Molecular Pattern Recognition and Anti-Tumor Immune Responses

    by Jie Chen, Shane M. Harding, Ramakrishnan Natesan, Lei Tian, Joseph L. Benci, Weihua Li, Andy J. Minn, Irfan A. Asangani, Roger A. Greenberg